DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Beyond sugar: How sweetener innovation is redefining taste and texture
With 72% of global consumers actively cutting sugar, sweetener suppliers are shifting from single-ingredient swaps to blended systems combining rare sugars, stevia, citrus flavonoids, and sweet proteins to replicate sugar's full functionality. EU market access for allulose remains stalled after EFSA's 2025 rejection, while AI formulation tools, sweet proteins, and bioconversion technologies emerge as key growth areas across beverages, bakery, and dairy.
The Evolution Of An Enzyme Engineer Who Changed Chemistry
Frances Arnold, a Nobel laureate, revolutionized chemistry with "directed evolution," a method to engineer enzymes for specific tasks. Her work involves harnessing evolution to create designer enzymes that accelerate chemical reactions, break down food, and build molecules. She discusses the future of this approach, including the use of AI tools for enzyme design, and her personal journey into science, highlighting the importance of curiosity and a willingness to challenge norms. Her research aims to solve global problems like developing tuberculosis drugs and degrading "forever chemicals" using these engineered enzymes.
A SHIFT IN ACHILLES CARE? REGENATIVE LABS AND DR. ROBERT PARKER ANNOUNCE PUBLICATION ON NON-SURGICAL OUTCOMES
Regenative Labs and Dr. Robert Parker have announced the publication of research on non-surgical outcomes in Achilles tendon defect care. The study highlights the use of Wharton's Jelly allografts as a structural connective tissue supplementation option within a conservative treatment pathway, potentially bridging the gap between conventional care and surgical intervention. This contributes to a growing body of evidence supporting evidence-informed non-surgical approaches that prioritize durable patient progress and reduce the need for surgery in musculoskeletal medicine.
The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies
The Blood Center in New Orleans has modernized its platelet processing by adopting Terumo Blood and Cell Technologies' FDA-cleared Reveos™ Automated Blood Processing System and Lumia™ Software Platform. This makes it the second U.S. blood center to implement Reveos, which automates whole blood separation into platelets, plasma, and red blood cells in a single centrifugation cycle. The technology addresses U.S. platelet shortages and staffing constraints by enabling faster, more efficient, and consistent production of whole blood-derived platelets, reducing manual steps, improving product consistency, and cutting waste, ultimately strengthening the blood supply for over 50 hospitals.
DNA Aptamer-Based Sensor: Aiming to Solve Key Challenges in Medical Settings
Nutromics is a MedTech company aiming to transform healthcare through continuous, real-time monitoring at the molecular level. It has developed a biosensor platform called the Smart Patch, designed to address key challenges in clinical settings such as the prevention and management of chronic diseases, the treatment of acute conditions, and therapeutic drug monitoring (TDM).
“Necoron” Sleep Support Device Prototype Unveiled for the First Time
Yukai Engineering Inc. (Headquarters: Shinjuku-ku, Tokyo; President: Shunsuke Aoki), which plans and develops numerous communication robots and IoT products under the vision “Making the world more fun with robotics,” will exhibit at CES 2026, the electronics and technology trade show held in Las Vegas, USA, from Tuesday, January 6, 2026, to Friday, January 9, 2026.
At our booth, we will showcase Yukai Engineering's latest robots, including the “Cat Tongue Puff Puff” first unveiled at last year's “CES 2025,” alongside examples of our development achievements resulting from collaborations with partner companies. We will debut the prototype of “necoron,” a baby sleep support device developed by Takara Tomy Co., Ltd., with Yukai Engineering contributing to the product design.
Furthermore, we plan to exhibit a new Yukai Engineering product making its debut at the event. Details will be announced at CES 2026.
Cambridge University's Revoice enables non-invasive speech restoration
A research team at Cambridge University has developed a choker-shaped wearable device called "Revoice" that successfully restores speech in real-time for patients with speech difficulties due to stroke after-effects, non-invasively. Revoice, equipped with ultra-sensitive sensors and AI, infers emotional states from subtle muscle vibrations and heart rate signals in the neck, and generates natural sentences from minimal mouth movements. Small-scale trials showed a low error rate, positioning it as a less burdensome communication aid compared to conventional invasive BCI or text input. Future plans include multi-language support, diverse emotion recognition, and large-scale clinical trials.
iotaMotion Receives FDA Clearance for Pediatric Use of iotaSOFT®, its Robotic-Assisted Cochlear Implant Insertion System
iotaMotion, Inc., developer of the FDA-approved iotaSOFT® robotic-assisted cochlear implant insertion system, has announced FDA 510(k) clearance for its pediatric use (ages four and up), expanding access to robotic-assisted cochlear implantation for school-aged children. The iotaSOFT system ensures precise and controlled electrode insertion during one of the most delicate steps of cochlear implant surgery, standardizing the procedure and potentially reducing variability, thereby offering greater confidence to parents considering implants for their children. Cincinnati Children's Hospital is the first pediatric center to adopt this system. Clinical studies indicate improved hearing preservation rates with robotic-assisted insertion compared to manual methods, a critical factor for early sound perception development in pediatric patients and for the success of future advanced therapeutic technologies.
Olorama Presents 'Blood': The New Immersive Scent for Multisensory Experiences
Olorama Technology, a leader in digital scent technology, has launched "Blood," a new immersive digital scent designed to deepen multisensory experiences in educational, entertainment, simulation, and immersive marketing environments. This new addition to its extensive library of over 200 scents offers content creators enhanced realism and emotional evocation for their projects. Expected applications include medical training simulators, VR experiences, themed audiovisual productions, and immersive games. Olorama's innovative technology provides "pure" scents without heating, preserving fidelity, and positions it as a leader in professional digital scent solutions.
Low-Irritation Skincare Manufacturer Natural Science Co., Ltd. Collaborates with Fukushima University to 'Visualize Surfactants in Stratum Corneum Using Imaging Technology'
Natural Science Co., Ltd., a low-irritation skincare manufacturer, successfully visualized surfactants in the stratum corneum using Imaging Mass Spectrometry (IMS) in collaboration with Fukushima University. This research visually demonstrated that combining anionic surfactants with amphoteric surfactants reduces their penetration into the stratum corneum, with less penetration observed deeper into the layers. The findings indicate IMS's utility in evaluating surfactant adsorption and penetration into the skin, expanding the scope of safety assessment and contributing to the development of even lower-irritation products.
Sleep.ai Launches Sleep Sense: Turn Any Smartphone into a Precision Sleep Tracker
Sleep Sense uses advanced AI, privacy-preserving design, and multimodal inference techniques to detect sleep and wake patterns without requiring audio recording or sensitive data capture. Its frictionless approach automatically infers sleep from signals such as device motion, light exposure, and usage patterns, supported by large-scale models trained on nearly one billion hours of sleep data. Hybrid spatio-temporal boundary detection accurately identifies bedtime and wake time, offering a level of confidence comparable to trackers validated against PSG while removing the operational burden of charging, syncing, or learning new hardware. All systems are GDPR- and ISO-compliant, designed so that nothing from inside the bedroom is recorded or transmitted.
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity Insider News Commentary – Traditional pharmaceutical strategies are giving ground as breakthrough approvals for gene therapies and mRNA platforms target previously untreatable rare diseases with precision interventions[1]. Healthcare systems integrating AI diagnostic tools now match therapies to individual genetic profiles rather than treating broad populations with reactive symptom management[2]. Five companies positioned at this convergence include Avant Technologies, Inc. (OTCQB: AVAI), Beam Therapeutics Inc. (NASDAQ: BEAM), CRISPR Therapeutics (NASDAQ: CRSP), Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), and Schrödinger, Inc. (NASDAQ: SDGR).
Tear Metabolism Profile: A Breakthrough Advancement Transforming the Diagnosis and Management of Diabetic Cataracts
In a groundbreaking advance that may transform the diagnosis and management of diabetic cataracts, researchers have unveiled a novel mass spectrometry-based strategy capable of detecting signature metabolites in tear fluid. This pioneering approach offers a minimally invasive window into the biochemical shifts occurring in the eyes of individuals suffering from diabetic cataracts, a major cause of vision impairment worldwide. By meticulously profiling the metabolic fingerprints of tears, scientists aim to unravel the complex molecular underpinnings of cataractogenesis in diabetic patients, potentially accelerating early detection and personalized treatment protocols.
The research team, led by Qi, Wang, Yan, and collaborators, harnessed cutting-edge high-resolution mass spectrometry to dissect the complex biochemical milieu of tear fluid collected from diabetic cataract patients. Tears, an easily accessible biofluid, harbor a diverse array of metabolites that reflect ocular health and systemic metabolic changes. Unlike traditional tissue biopsy or invasive ophthalmic procedures, analyzing tear fluid provides a fast, patient-friendly avenue for biomarker discovery. This strategy not only reduces dependency on cumbersome diagnostic practices but also opens new horizons for routine screening in vulnerable populations.